P1219: zanubrutinib, lenalidomide plus r-chop (zr2-chop) as the first-line treatment for non-gcb diffused large b-cell lymphoma (dlbcl)
HemaSphere(2022)
关键词
lymphoma,zanubrutinib,dlbcl,lenalidomide,r-chop,first-line,non-gcb,b-cell
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要